Correlation Between 23Andme Holding and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Moleculin Biotech, you can compare the effects of market volatilities on 23Andme Holding and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Moleculin Biotech.

Diversification Opportunities for 23Andme Holding and Moleculin Biotech

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between 23Andme and Moleculin is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Moleculin Biotech go up and down completely randomly.

Pair Corralation between 23Andme Holding and Moleculin Biotech

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Moleculin Biotech. In addition to that, 23Andme Holding is 1.11 times more volatile than Moleculin Biotech. It trades about -0.21 of its total potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 per unit of volatility. If you would invest  262.00  in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  Moleculin Biotech

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Moleculin Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

23Andme Holding and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Moleculin Biotech

The main advantage of trading using opposite 23Andme Holding and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind 23Andme Holding Co and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Correlations
Find global opportunities by holding instruments from different markets